Gene targeting in animal cells using isogenic DNA constructs

• US 5,789,215 A
• Filed: 08/07/1997
• Issued: 08/04/1998
• Est. Priority Date: 08/20/1991
• Status: Expired due to Term

• Current Assignee: Genpharm Incorporated (Bristol-Myers Squibb Company)
• Original Assignee: Genpharm Incorporated (Bristol-Myers Squibb Company)
• Inventors: Berns, Anton, Robanus Maandag, Els, te Riele, Hein
• Primary Examiner(s): Stanton, Brian R.
• Application Number:
  US08/908,348
• Time in Patent Office: 362 Days
• Field of Search: 435/172.1, 435/172.3, 435/320.1, 435/325, 435/326, 800/2, 935/50, 935/56, 935/34, 935/53, 935/70, 935/71, 935/83, 935/84
• US Class Current: 800/25
• CPC Class Codes: C12N 15/85 for animal cells
• CPC Class Codes: C12N 15/902 using homologous recombination

Abstract

The present invention provides novel methods for modifying the genome of an animal cell which typically comprise the steps of: constructing a DNA molecule in which desired sequence modifications are contained in a segment of DNA (a "targeting DNA") that is substantially isogenic with a DNA in the cell genome (a."target DNA"); introducing the targeting DNA construct into the cell (e.g., by microinjection, electroporation, transfection, or calcium phosphate precipitation); and selecting cells in which the desired sequence modifications have been introduced into the genome via homologous recombination.

Claims

1. A method for modifying the genome of a target cell of a multicellular animal by homologous recombination between a target DNA sequence in the target cell genome and a targeting DNA molecule introduced into the cell, said method comprising:

a) constructing a targeting DNA molecule in which a desired sequence modification is contained in a targeting segment of DNA that is isogenic with the target DNA sequence in the target cell genome;

b) introducing said targeting DNA molecule into target cells; and

c) isolating a target cell in which said targeting DNA molecule is incorporated into its genome following homologous recombination between said targeting DNA molecule and said target DNA sequence thereby modifying the cell genome of said of said target cell of said multicellular animal;

wherein the introducing step and the isolating step are performed in vitro, and further provided that where the target cell is an embryonic stem cell, the embryonic stem cell is murine.

2. A method according to claim 1, wherein the multicellular animal is a mammal.

3. A method according to claim 1, wherein the desired sequence modification in the targeting DNA segment comprises an insertion of a selectable marker.

4. A method according to claim 3, wherein the selectable marker is a gene conferring resistance to a compound inhibitory to cell growth.

5. A method according to claim 3 wherein the selectable marker is a gene conferring the ability to grow on a selected substrate.

6. A method according to claim 1, wherein the targeting DNA molecule is introduced into the cell by microinjection.

7. A method according to claim 1, wherein the target DNA is an immunoglobulin gene.

8. The method of claim 1 further comprising isolating the targeting segment of DNA, and incorporating the isolated targeting segment into the targeting construct.

9. The method of claim 8, wherein the targeting segment and the target cell are from the same inbred mouse strain.

10. The method of claim 9, wherein the targeting segment is from a strain 129 mouse and the target cell is from a strain 129 mouse.

11. In a method of in vitro gene targeting comprising introducing a targeting DNA construct bearing a desired DNA sequence modification into a target cell of a multicellular eukaryotic organism in vitro whereby the construct undergoes homologous recombination with a target DNA sequence in the genome of the target cell thereby introducing the desired sequence modification into the genome of said cell, the improvement comprising preparing said targeting DNA construct by introducing said desired DNA sequence modification into a targeting segment of DNA that is isogenic with the target DNA sequence in the target cell genome.

12. The method of claim 11 wherein the targeting segment of DNA is at least 1000 base pairs in length.

13. The method of claim 11 wherein the improvement further comprises the additional step of isolating said targeting segment of DNA is from a cell of the same multicellular eukaryotic organism from which the target cell is prepared.

14. The method of claim 11, wherein the multicellular eucaryotic organism is a noninbred animal.

15. The method of claim 11, wherein the multicellular euracyotic organism is a mammal.

16. The method of claim 11 further comprising isolating the targeting segment of DNA, and incorporating the isolated targeting segment into the targeting construct.

17. The method of claim 16 wherein the targeting segment and the target cell are from the same inbred mouse strain.

18. The method of claim 17, wherein the targeting segment is from a strain 129 mouse and the target cell is from a strain 129 mouse.